Optimal Management of the Inpatient With Decompensated Cirrhosis
- PMID: 39889207
- DOI: 10.1097/MCG.0000000000002143
Optimal Management of the Inpatient With Decompensated Cirrhosis
Abstract
Over the past several years, there has been a wealth of new data pertaining to the management of complications of cirrhosis, resulting in several important updates to best practices and consensus guidelines. Despite these advancements and numerous recent targeted quality initiatives, hospitalizations resulting from complications of cirrhosis remain frequent, costly and associated with poor patient outcomes. An emphasis on evidence-based management of hospitalized patients with decompensated cirrhosis has the potential to decrease readmission rates and length of stay while improving overall patient outcomes. Herein, we provide an updated, evidence-based overview of the optimal inpatient management of the most frequently encountered complications associated with cirrhosis.
Keywords: HRS; ascites; cirrhosis; decompensated cirrhosis; hepatic encephalopathy; hepatorenal syndrome; spontaneous bacterial peritonitis; variceal bleeding.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Similar articles
-
Hospital readmissions among patients with decompensated cirrhosis.Am J Gastroenterol. 2012 Feb;107(2):247-52. doi: 10.1038/ajg.2011.314. Epub 2011 Sep 20. Am J Gastroenterol. 2012. PMID: 21931378 Free PMC article.
-
Impact of physician specialty on quality care for patients hospitalized with decompensated cirrhosis.PLoS One. 2015 Apr 2;10(4):e0123490. doi: 10.1371/journal.pone.0123490. eCollection 2015. PLoS One. 2015. PMID: 25837700 Free PMC article.
-
Real-world clinical features, health-care utilization, and economic burden in decompensated cirrhosis patients: A national database.J Gastroenterol Hepatol. 2022 Nov;37(11):2154-2163. doi: 10.1111/jgh.15962. Epub 2022 Jul 29. J Gastroenterol Hepatol. 2022. PMID: 35862281
-
Presentation and complications associated with cirrhosis of the liver.Curr Med Res Opin. 2015 May;31(5):925-37. doi: 10.1185/03007995.2015.1021905. Curr Med Res Opin. 2015. PMID: 25697811 Review.
-
AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review.Gastroenterology. 2024 Jan;166(1):202-210. doi: 10.1053/j.gastro.2023.10.016. Epub 2023 Nov 18. Gastroenterology. 2024. PMID: 37978969 Review.
References
-
- Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and Hepatorenal Syndrome: 2021 practice guidance by the American Association for the study of liver diseases. Hepatology. 2021;74:1014–1048.
-
- Angeli P, Bernardi M, Villanueva C, et al. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406–460.
-
- Karvellas CJ, Bajaj JS, Kamath PS, et al. AASLD practice guidance on acute-on-chronic liver failure and the management of critically ill patients with cirrhosis. Hepatology. 2023;79:1463–1502.
-
- Abraldes JG, Caraceni P, Ghabril M, et al. Update in the treatment of the complications of cirrhosis. Clin Gastroenterol Hepatol. 2023;21:2100–2109.
-
- Hirode G, Saab S, Wong RJ. Trends in the burden of chronic liver disease among hospitalized US adults. JAMA Network Open. 2020;3:e201997.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous